Application 211125
- Type
- ANDA
- Sponsor
- TEVA PHARMS USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | FOR SUSPENSION;ORAL | EQ 6MG BASE/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-8180 | Oseltamivir Phosphate | Oseltamivir Phosphate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-8180 | Oseltamivir Phosphate | Oseltamivir Phosphate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 50090-4613 | Oseltamivir Phosphate | Oseltamivir Phosphate | A-S Medication Solutions | ANDA | Current |